Skip to content
Politically.com Search all
Menu

New Jersey 222

A 4852

Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Source: Open States / PluralUpdated 2026-09-20 01:12:03 UTC.

Official record

Measure details

Jurisdiction
New Jersey
Session
222
Chamber
lower
Classification
bill
Subjects
Not supplied
Introduced / first action
2026-05-04 04:00:00

Sponsors

Source-supplied history

Actions

  1. Approved P.L.2026, c.40.

  2. Passed Senate (Passed Both Houses) (38-2)

    passage
  3. Substituted for S4194/4210 (SCS)

  4. Received in the Senate without Reference, 2nd Reading

    reading-2
  5. Passed by the Assembly (76-2-1)

  6. Reported from Assembly Comm. as a Substitute, 2nd Reading

    reading-2
  7. Transferred to Assembly State and Local Government Committee

    referral-committee
  8. Introduced, Referred to Assembly Health Committee

    introduction, referral-committee

Recorded votes

Roll calls

No recorded vote is supplied for this bill.